Lucid Diagnostics (LUCD) vs Microbot Medical (MBOT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lucid Diagnostics (LUCD) has outperformed Microbot Medical (MBOT) over the past year, losing 46.7% versus a loss of 67.5%. Over five years, MBOT leads with a -85.1% price change compared with -93.0% for LUCD. Lucid Diagnostics is the larger company by market cap ($124.1 million vs $71.9 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUCD | MBOT |
|---|---|---|
| Share price | $0.65 | $1.07 |
| Market cap | $124.12M | $71.87M |
| 1-day change | -0.02% | -4.46% |
| YTD return | -40.36% | -46.50% |
| 1-year return | -46.71% | -67.48% |
| 5-year return | -93.05% | -85.08% |
| EPS (TTM) | $-0.44 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.63 | $3.17 |
| 52-week low | $0.50 | $1.05 |
| Distance from 52-week high | -60.10% | -66.25% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +515.38% | +491.59% |
| Average volume | 1.35M | 649.10K |
| Shares outstanding | 190.95M | 67.16M |
| Employees | 82 | 43 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LUCD has outperformed MBOT by 20.8 percentage points over the past year.
About Lucid Diagnostics
LUCD stock →Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.
Health Care · Medical/Dental Instruments · 82 employees
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
LUCD vs MBOT FAQ
Which is bigger, Lucid Diagnostics or Microbot Medical?
Lucid Diagnostics (LUCD) is larger, with a market capitalization of $124.12M compared with $71.87M for Microbot Medical (MBOT).
Which stock has performed better over the past year, LUCD or MBOT?
LUCD returned -46.71% over the past 12 months, compared with -67.48% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are Lucid Diagnostics and Microbot Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.